| Nov 19 |
Eli Lilly Stock Eyes Worst Month Since February 2009: Is It Time To Buy The Dip?
|
| Nov 19 |
Eli Lilly's Investigational Drug Cuts Sticky Cholesterol Levels By Almost 86%
|
| Nov 19 |
Jim Cramer: Coinbase Is A 'Winner,' Suggests Buying This 'Hated' Big Pharma Stock
|
| Nov 19 |
Here’s Why Eli Lilly and Company (LLY) is on Detractors’ List of Madison Sustainable Equity Fund
|
| Nov 19 |
Market Chatter: Eli Lilly, Novo Nordisk Press Employers to Cover the Cost of Weight-Loss Drugs
|
| Nov 19 |
Makers of Weight-Loss Drugs Want Your Employer to Pay for Them
|
| Nov 18 |
RFK Jr.'s HHS nomination sparks concern over pharma stocks
|
| Nov 18 |
Lilly heart drug muvalaplin significantly reduces lipoprotein(a) levels
|
| Nov 18 |
Lilly's muvalaplin lowered lipoprotein(a) levels in adults with high risk for cardiovascular events by up to 85% at highest tested dose
|
| Nov 18 |
Novo Nordisk reportedly launches Wegovy in China
|
